Targeting Microglia Using Cx3cr1-Cre Lines: Revisiting the Specificity
Open accessAbstract
Microglia play a pivotal role in maintaining homeostasis of the CNS. There is growing interest in understanding how microglia influence normal brain function and disease progression. Several microglia-specific Cx3cr1-Cre lines have been developed and have become indispensable tools in many investigations of microglial function. However, some recent studies have reported that these lines may have significant leakage into neurons. Other studies have reported that Cx3cr1 is expressed in non-microglial cells, including neurons and astrocytes, in vitro or in vivo either during brain development or upon neurological insult. All these reports raise serious concerns about the trustworthiness of these Cre-lines and whether the conclusions drawn from previous studies are valid. Here, we found that a floxed fluorescent reporter mouse line which has been frequently used to verify Cre lines displayed spontaneous expression of the GFP reporter, independent of Cre recombinase, thus revealing a potential caveat in assessing cre lines. We further confirmed that two Cx3cr1-Cre mouse lines can drive fluorescent reporter expression largely restrictively in microglia. Finally, we clarified that these two mouse lines maintain microglia-specific expression even following excitatory injury. Together, our findings confirm that two previously created Cx3cr1-Cre lines remain as invaluable tools for studying microglia. Moreover, to ensure the quality of data generated and the soundness of conclusions drawn from such data, it should be compulsory to thoroughly examine reporter lines for spontaneous leakiness when labeling cells to study CNS function and diseases.
AI snapshot
Written from the paper’s full text.
TL;DR
This study re-evaluates Cx3cr1-Cre microglia specificity and finds that two commonly used floxed fluorescent reporter lines, Rosa-Green and tdTomato, can leak independent of Cre, whereas mT/mG does not. It confirms that Cx3cr1-CreM and Cx3cr1-CreERT2J lines largely restrict reporter expression to microglia, including after pilocarpine-induced status epilepticus, though the inducible line has tamoxifen-independent basal activity.
Key findings
- Rosa-Greenf/f mice showed spontaneous, Cre-independent GFP leakiness: 33.33% of animals had significant GFP expression throughout the brain; among GFP+ cells, cortex Iba1+/NeuN+/GFAP+ populations were 2.80 ± 2.45%, 17.42 ± 15.66%, and 0%, and hippocampus populations were 0%, 41.71 ± 15.45%, and 0.47 ± 0.83%, respectively. Triple-negative GFP+ cells were 79.8% in cortex and 57.8% in hippocampus.
- tdTomatof/f mice showed Cre-independent tdTomato leakage in all seven animals examined, predominantly vascular and colocalized with lectin; cortex Iba1+/NeuN+/GFAP+ populations were 2.00 ± 4.5%, 4.00 ± 8.9%, and 0%, and hippocampus values were 0, 44 ± 0.9%, 0.70 ± 1.6%, and 0.88 ± 1.2% as reported. In contrast, mT/mGf/f mice showed no mGFP leakage in all seven mice examined.
- Cx3cr1-CreM±;Rosa-Greenf/- mice had 99.2 ± 0.3% and 99.8 ± 0.16% of microglia GFP-positive in cortex and hippocampus; NeuN+/GFP+ were 0.13 ± 0.5% and 0%, and GFAP+/GFP+ were 0% and 0.2 ± 0.5%. With mT/mG, 99.9 ± 0.17% and 99.7 ± 0.36% of GFP+ cells were Iba1+ in cortex and hippocampus, with none NeuN+ or GFAP+.
- Cx3cr1-CreERT2J±;mT/mGf/- mice showed basal Cre activity without tamoxifen: up to 18.9 ± 4.3% and 23.0 ± 3.4% of Iba1+ cells were GFP+ in cortex and hippocampus; after tamoxifen, all Iba1+ cells were GFP+, with none NeuN+ or GFAP+. After pilocarpine-induced status epilepticus, Cx3cr1-CreM±;Rosa-Greenf/- showed 98.8 ± 1.1% and 99.6 ± 0.24% of GFP+ cells as Iba1+ in cortex and hippocampus, and Cx3cr1-Cre±;mT/mGf/- showed 99.9 ± 0.13% and 100% GFP+ microglia.
Methods
- Male and female mice were used, including Rosa-Greenf/f, tdTomatof/f, mT/mGf/f, Cx3cr1-CreERT2, and Cx3cr1-CreM lines; brains were harvested at around two to six months for reporter evaluation, around two months for Cx3cr1-CreM crosses, and after tamoxifen or pilocarpine treatment as specified.
- Immunohistochemistry used antibodies against GFP, Iba1, NeuN, and GFAP, with lectin for blood vessels; 35-µm coronal sections near bregma –2 mm were imaged by confocal microscopy, and GFP+/Iba1+, GFP+/NeuN+, and GFP+/GFAP+ cells were quantified in cortex, CA1, CA3, and dentate gyrus.
- Tamoxifen was given at 100 mg/kg i.p. for five consecutive days; pilocarpine was given with methyl scopolamine to induce status epilepticus for 4 h, with brains harvested 3 d post-status epilepticus; data were analyzed with GraphPad Prism 7 and presented as mean ± SEM.
Limitations
- The paper does not include a formal limitations section; it states that the exact mechanism of spontaneous leakiness in Rosa-Greenf/f and tdTomatof/f remains unclear, that no reliable anti-Cx3cr1 antibody is available, and that discrepancies with prior studies require further study.
- Evident from the text: sample sizes are small, often two to three mice per group, with seven mice for reporter-line evaluations, and sex distributions are not balanced across all experiments.
- Evident from the text: quantification is restricted to selected cortical and hippocampal regions, and the authors note that prior reported ~10% neuronal leakage in the Cx3cr1-CreM line was not accompanied by data, leaving external validation incomplete.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
33 of 36 cited sources checked · 10 supported · 8 flagged · accuracy not yet measured
- Premisecitation
No leakiness was reported in those studies using the YFP reporter line to verify two inducible Cx3cr1-CreERT2 lines.
“No leakiness was reported in those studies.”
Quote in the paperSubstantial claim2 of 2 sources checked- cites Jung et al., 2000 source
The Results and Discussion describes a CX3CR1–EGFP knock-in mouse, not YFP reporter validation of two inducible Cx3cr1-CreERT2 lines. Searches for YFP, inducible Cre and leakiness found no passage addressing whether those lines showed uninduced reporter activity. Page numbers were not available in our copy. (LLM, conf=0.78)
Experimental — accuracy not yet measured - cites Parkhurst et al., 2013 source
The Results section, “Generation of CX3CR1CreER mice to manipulate gene expression in microglia” (page not available), reports DsRed-positive microglia even without tamoxifen, contrary to the claim that no leakiness was reported. EYFP marked cells expressing the CreER transcript; the paper used a DsRed reporter to test Cre-mediated recombination. (LLM, conf=0.89)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
- Findingown data
The inducible Cx3cr1-CreERT2 line developed by Jung et al. (2000) displayed some basal cre activity without tamoxifen treatment.
“The inducible Cx3cr1-CreERT2 line developed by Jung et al. (2000), displayed some basal cre activity without tamoxifen treatment, but this expression was restricted to microglia.”
- Also stated in: § Discussion · plain
“We found that this inducible line can drive expression of GFP reporter in a fraction of microglia before tamoxifen treatment.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Jung et al. (2000) source
The Results and Discussion describe a CX3CR1–GFP knock-in mouse, not an inducible Cx3cr1-CreERT2 line. Materials and Methods say Cre was introduced transiently into embryonic stem cells to remove a selection gene; the paper does not report basal Cre activity or tamoxifen treatment. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
- Also stated in: § Discussion · plain
- Findingown data
This basal cre activity in the Cx3cr1-CreERT2 line developed by Jung et al. (2000) was restricted to microglia.
“The inducible Cx3cr1-CreERT2 line developed by Jung et al. (2000), displayed some basal cre activity without tamoxifen treatment, but this expression was restricted to microglia.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Jung et al. (2000) source
The Results and Discussion describe a CX3CR1-GFP reporter mouse, not an inducible Cx3cr1-CreERT2 line. Materials and Methods say Cre was used transiently in embryonic stem cells to remove a selection cassette; the paper does not report basal Cre activity or tamoxifen treatment. Its GFP expression was also observed in peripheral blood monocytes, not only microglia. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
- Premisecitation
According to The Jackson Laboratory website, the constitutive Cx3cr1-Cre line created by Jung et al. (2000) displays leakiness into neurons when crossed with a yellow fluorescent protein (YFP) reporter line.
“According to the description on The Jackson Laboratory website, the constitutive Cx3cr1-Cre line created by Jung et al. (2000), displays leakiness into neurons when crossed with a yellow fluorescent protein (YFP) reporter line.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Jung et al. (2000) source
The Results and Discussion section (‘Generation of CX3CR-1GFP mice’; page not provided) says Jung et al. generated a CX3CR1–EGFP replacement line, not a constitutive Cx3cr1-Cre line. The Methods say Cre was used transiently in embryonic stem cells to remove the neo gene. The paper does not report a YFP-reporter cross or neuronal leakiness. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
- Interpretationreasoning
The partial tamoxifen-independent cre activity observed in the Cx3cr1-CreERT2 line developed by Jung et al. (2000) indicates potential embryonic deletion of TSC1 in a fraction of microglia.
“The partial tamoxifen-independent cre activity observed in the Cx3cr1-CreERT2 line developed by Jung et al. (2000), indicates potential embryonic deletion of TSC1 in a fraction”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Jung et al. (2000) source
The Results and Discussion section identifies the line Jung et al. generated as CX3CR1-GFP mice, not Cx3cr1-CreERT2 mice. Materials and Methods says Cre was used transiently in embryonic stem cells to remove a selectable marker; it does not report tamoxifen-independent Cre activity or TSC1 deletion in microglia. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
- Interpretationown data
The cre activity in the Cx3cr1-CreERT2 line developed by Jung et al. (2000) is not fully dependent on tamoxifen.
“Thus, the cre activity in this line is not fully dependent on tamoxifen.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Jung et al. (2000) source
The Results and Discussion (page not available) identify the line Jung et al. generated as CX3CR1-GFP, with EGFP replacing part of the CX3CR1 gene—not a Cx3cr1-CreERT2 line. Materials and Methods (page not available) mention Cre only as a vector transiently introduced into embryonic stem cells to remove a selection gene. The paper does not assess tamoxifen dependence. (LLM, conf=0.86)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
- Premisecitation
The inducible Cx3cr1-CreERT2 mouse line developed by Parkhurst et al. displayed a reasonable level of microglial-specificity in their hands.
“The inducible Cx3cr1-CreERT2 mouse line that was developed by Parkhurst et al., displayed a reasonable level of microglial-specificity in their hands (Parkhurst et al., 2013).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Parkhurst et al., 2013 source
- Interpretationown data
This cre-independent leakage likely accounts, at least in part, for the GFP-positive non-microglial cells observed in Zhang et al. (2018).
“This cre-independent leakage likely accounts, at least in part, for the GFP-positive non-microglial cells observed in that previous study (Zhang et al., 2018).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Zhang et al., 2018 source
- Interpretationown data
Our study suggests the Rosa-Greenf/f reporter line itself could contribute to the leakage into neurons and other cells noted by others (Zhang et al., 2018).
“Our study suggests that the Rosa-Greenf/f reporter line itself could contribute to the leakage into neurons and other cells that was noted by others (Zhang et al., 2018).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Zhang et al., 2018 source
- Premisecitation
Zhang et al. (2018) reported that the Parkhurst Cx3cr1-CreERT2 line has significant leakage into neurons.
“However, Zhang et al. (2018) reported that this line has significant leakage into neurons.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Zhang et al., 2018 source
The Results (page unavailable) report neuronal Cre-recombination, but the large neuronal involvement was found with constitutive Cx3cr1-Cre. For the inducible Cx3cr1-CreER line, they report about 5% of cortical neurons showing recombination; Materials and Methods (page unavailable) identify that line as Litt/Wgan, not Parkhurst. The paper therefore does not establish significant neuronal leakage in the Parkhurst line. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Findingown data
The Rosa-Greenf/f reporter line used in a previous study by Zhang et al. (2018) shows spontaneous leakiness into non-microglial cells in the absence of cre recombinase.
“In the present study, we unexpectedly found that the Rosa-Greenf/f reporter line used in a previous study by other researchers (Zhang et al., 2018) shows spontaneous leakiness into non-microglial cells in the absence of cre recombinase.”
- Also stated in: § Discussion · plain
“Surprisingly, however, the Rosa-Greenf/f and tdTomatof/f lines displayed spontaneous leakiness independent of cre recombinase.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Zhang et al., 2018 source
- Also stated in: § Discussion · plain
- Premisecitation
The YFP reporter line was used to verify two inducible Cx3cr1-CreERT2 lines (Jung et al., 2000; Parkhurst et al., 2013).
“The YFP reporter line was used to verify two inducible Cx3cr1-CreERT2 lines (Jung et al., 2000; Parkhurst et al., 2013).”
Quote in the paperSubstantial claim2 of 2 sources checked- cites Jung et al., 2000 source
The Results and Discussion section (page not provided) describes a Cx3cr1 EGFP reporter mouse line, supporting only the identification of a Cx3cr1 fluorescent reporter. It describes neither a YFP reporter nor the use of that line to verify two inducible Cx3cr1-CreERT2 lines. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites Parkhurst et al., 2013 source
The Results section, “Generation of CX3CR1CreER mice” (page not provided), describes one inducible line with a built-in EYFP element and uses EYFP to assess its expression. It does not say that a separate YFP reporter line verified two inducible lines; Cre activity was tested with a DsRed reporter instead. (LLM, conf=0.87)
Experimental — accuracy not yet measured
- Findingcitation
Among the three fluorescent reporters tested, the mT/mG reporter line appears to consistently deliver GFP reporter expression in a cre-dependent manner.
“Among the three fluorescent reporters tested, the mT/mG reporter line appears to consistently deliver GFP reporter expression in a cre-dependent manner, not only in the present study, but also in many other studies (Zhao et al., 2018).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Zhao et al., 2018 source
The Experimental Procedures (Animals; page unavailable) identify the Rosa mT/mG line among the mice used, so Zhao et al. is an example of a study using that line. Our copy does not report whether the line consistently produced Cre-dependent GFP expression or compare it with other fluorescent reporters. (LLM, conf=0.78)
Experimental — accuracy not yet measured
- Premisecitation
No spontaneous seizures were observed in the Zhang et al. (2018) study that used the Parkhurst Cx3cr1-CreERT2 line.
“In contrast, no spontaneous seizures were observed in the other study (Zhang et al., 2018) that used the Cx3cr1-CreERT2 mouse line developed by Parkhurst et al. (2013).”
Quote in the paperSubstantial claim2 of 2 sources checked - Premisecitation
On tamoxifen treatment, a fraction of mice in Zhao et al. (2018) displayed spontaneous seizures.
“On tamoxifen treatment, a fraction of mice displayed spontaneous seizures.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Zhao et al. (2018) source
- Interpretationreasoning
This potential embryonic deletion of TSC1 may explain the differences in seizure susceptibility observed in these two studies (Jung et al., 2000; Zhang et al., 2018; Zhao et al., 2018).
“which may explain the differences in seizure susceptibility observed in these two studies (Jung et al., 2000; Zhang et al., 2018; Zhao et al., 2018).”
Quote in the paperSubstantial claim3 of 3 sources checked- cites Jung et al., 2000 source
The Results and Discussion describe CX3CR1 deletion and GFP expression in microglia, while Materials and Methods describe the targeting procedure. Neither section addresses TSC1 deletion, seizure susceptibility, or differences between the two studies; searches for those terms found no supporting passage in our copy. (LLM, conf=0.76)
Experimental — accuracy not yet measured - cites Zhang et al., 2018 source
The Discussion says constitutive Tsc1 deletion involved presumed embryonic induction and that prenatal, unlike postnatal, microglial deletion might be sufficient to cause epilepsy. But it does not propose embryonic deletion as the explanation for the seizure difference between the two studies: it notes that the other study also found seizures after postnatal deletion and discusses neuronal involvement, genetic background, and recombination efficiency as possible factors. Page numbers are unavailable in our copy. (LLM, conf=0.82)
Experimental — accuracy not yet measured - cites Zhao et al., 2018 source
The Results section (page unavailable) reports seizures after TSC1 deletion in microglia and acknowledges that deletion during brain development could contribute to epilepsy. It also reports seizures after deletion in adult mice. The paper does not attribute differences in seizure susceptibility between the two cited studies to potential embryonic deletion. (LLM, conf=0.80)
Experimental — accuracy not yet measured
- Premisecitation
In Zhao et al. (2018), the Cx3cr1-CreERT2 line developed by Jung et al. (2000) was employed to deplete TSC1 in microglia.
“In the study by Zhao et al. (2018), this line was employed to deplete TSC1 in microglia.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Zhao et al. (2018) source
The Results section (‘Elevated mTOR Signaling in Microglia Is Sufficient to Promote the Development of SRSs’; page unavailable) confirms that Zhao et al. crossed a Cx3cr1-CreERT2 line with TSC1-floxed mice to delete TSC1 in microglia. It identifies the Cx3cr1-CreERT2 line with Parkhurst et al. (2013), not Jung et al. (2000), so the claim's identification of the line is unsupported. (LLM, conf=0.90)
Experimental — accuracy not yet measured
- Findingown data
A floxed fluorescent reporter mouse line frequently used to verify Cre lines displays spontaneous GFP reporter expression independent of Cre recombinase.
“Here, we found that a floxed fluorescent reporter mouse line which has been frequently used to verify Cre lines displayed spontaneous expression of the GFP reporter, independent of Cre recombinase, thus revealing a potential caveat in assessing cre lines.”
Quote in the paperSubstantial claim - Findingown data
In Rosa-Greenf/f mice examined at around two to six months of age, 33.33% of animals displayed significant GFP reporter expression throughout the brain, from sporadic cells to clusters.
“To our surprise, 33.33% of the animals displayed significant expression of GFP reporter throughout the brain, from individually sporadic GFP-positive cells to clusters (Fig. 1A,C; Extended Data Fig. 1-1A).”
Quote in the paperSubstantial claim - Findingown data
In vehicle treated Cx3cr1-CreERT2J±;mT/mGf/- mice, up to 18.9 ± 4.3% of Iba1+ cells are GFP positive in the cortex.
“In vehicle treated mice, up to 18.9 ± 4.3% and 23.0 ± 3.4% of Iba1+ cells are GFP positive in the cortex and hippocampus, respectively.”
Quote in the paperSubstantial claim - Findingown data
Occasionally, a small fraction of tdTomato mice displayed very broad spontaneous leakage.
“Of note, occasionally, a small fraction of tdTomato mice displayed very broad spontaneous leakage.”
Quote in the paperNot a substantial claim - Findingown data
A significant portion of GFP-positive cells in Rosa-Greenf/f mice are Iba1/NeuN/GFAP triple negative: 79.8% in cortex and 57.8% in hippocampus.
“Therefore, a significant portion of GFP-positive cells are Iba1/NeuN/GFAP- triple negative in the cortex (79.8%) and hippocampus (57.8%; two males and one female).”
Quote in the paperSubstantial claim - Findingown data
The Cx3cr1-CreM line from MMRRC is reasonably microglia specific.
“We have also confirmed that the Cx3cr1-CreM line from MMRRC is reasonably microglia specific.”
- Also stated in: § Discussion · plain
“In the present study, we verified that the constitutive Cx3cr1-CreM line from the MMRRC is microglia specific.”
Quote in the paperSubstantial claim - Also stated in: § Discussion · plain
- Findingown data
In Cx3cr1-Cre±;mT/mGf/- mice after SE, few, if any, NeuN+/GFP+ double-positive cells were seen.
“We saw few, if any, NeuN+/GFP+ or GFAP+/GFP+ double-positive cells.”
Quote in the paperSubstantial claim - Findingown data
A GFP reporter mouse line used in a previous study displays spontaneous leakiness into neurons, independent of Cre recombinase.
“We found that a GFP reporter mouse lines used in a previous study displays spontaneous leakiness into neurons, independent of Cre recombinase.”
Quote in the paperSubstantial claim - Findingown data
The tdTomatof/f line displayed spontaneous leakiness independent of cre recombinase.
“Surprisingly, however, the Rosa-Greenf/f and tdTomatof/f lines displayed spontaneous leakiness independent of cre recombinase.”
Quote in the paperSubstantial claim - Findingown data
None of the other GFP+ cells are GFAP-positive in Cx3cr1-CreM±;Rosa-Greenf/- mice after SE.
“Among the other GFP+ cells, only 0.31 ± 0.54% and 0.07 ± 0.13% are NeuN positive in the cortex and hippocampus, respectively and none of them are GFAP-positive (Fig. 4A–D).”
Quote in the paperSubstantial claim - Findingown data
In the hippocampus of Rosa-Greenf/f mice, Iba1+, NeuN+, and GFAP+ populations among GFP-positive cells are 0%, 41.71 ± 15.45%, and 0.47 ± 0.83%, respectively.
“In the hippocampus, Iba1+, NeuN+, and GFAP+ populations are 0%, 41.71 ± 15.45%, and 0.47 ± 0.83%, respectively.”
Quote in the paperSubstantial claim - Findingown data
In Cx3cr1-CreM±;Rosa-Greenf/- mice after pilocarpine-induced SE, 98.8 ± 1.1% of GFP+ cells were Iba1-positive in the cortex.
“In Cx3cr1-CreM±;Rosa-Greenf/-, we found that 98.8 ± 1.1% and 99.6 ± 0.24% of GFP+ cells were Iba1-positive in the cortex and hippocampus, respectively (two males and one female).”
Quote in the paperSubstantial claim - Findingown data
In Cx3cr1-Cre±;mT/mGf/- mice after SE, few, if any, GFAP+/GFP+ double-positive cells were seen.
“We saw few, if any, NeuN+/GFP+ or GFAP+/GFP+ double-positive cells.”
Quote in the paperSubstantial claim - Findingown data
In Cx3cr1-Cre±;mT/mGf/- mice after SE, 99.9 ± 0.13% of GFP-positive cells were microglia in the cortex.
“Moreover, in Cx3cr1-Cre±;mT/mGf/- mice, we observed that nearly all GFP-positive cells were microglia (99.9 ± 0.13% in the cortex and 100% in the hippocampus; two males and one female; Fig. 4E–H).”
Quote in the paperSubstantial claim - Findingown data
Several dozens of non-microglial GFP-positive cells were scattered sporadically throughout the entire brain in Cx3cr1-CreM±;Rosa-Greenf/- mice.
“However, we also observed several dozens of non-microglial GFP-positive cells scattered sporadically throughout the entire brain (Fig. 2A–D; Extended Data Fig. 2-1A–C).”
Quote in the paperSubstantial claim- Rests on an assumption: Endogenous Cx3cr1 is a selective marker for microglia in the CNS.
- Findingown data
These two Cx3cr1-Cre mouse lines maintain microglia-specific expression even following excitatory injury.
“Finally, we clarified that these two mouse lines maintain microglia-specific expression even following excitatory injury.”
Quote in the paperSubstantial claim- Rests on an assumption: Endogenous Cx3cr1 is a selective marker for microglia in the CNS.
- Findingown data
In Cx3cr1-Cre±;mT/mGf/- mice after SE, 100% of GFP-positive cells were microglia in the hippocampus.
“Moreover, in Cx3cr1-Cre±;mT/mGf/- mice, we observed that nearly all GFP-positive cells were microglia (99.9 ± 0.13% in the cortex and 100% in the hippocampus; two males and one female; Fig. 4E–H).”
Quote in the paperSubstantial claim - Findingown data
All seven tdTomato reporter mice examined displayed significant leakage of tdTomato in the brain.
“We found that the seven animals examined display significant leakage of tdTomato in the brain (four males and three females; Fig. 1B,D).”
Quote in the paperSubstantial claim - Findingown data
Two Cx3cr1-Cre mouse lines can drive fluorescent reporter expression largely restrictively in microglia (are microglia-specific).
“We further confirmed that two Cx3cr1-Cre mouse lines can drive fluorescent reporter expression largely restrictively in microglia.”
- Also stated in: § Significance Statement · boosted
“Furthermore, we confirmed that two Cre-lines are microglia-specific and thus can be redeployed without hesitation.”
Quote in the paperSubstantial claim- Rests on an assumption: Endogenous Cx3cr1 is a selective marker for microglia in the CNS.
- Also stated in: § Significance Statement · boosted
- Findingown data
In Cx3cr1-Cre±;mT/mGf/- mice, 99.9 ± 0.17% and 99.7 ± 0.36% of GFP-positive cells were Iba1 positive in the cortex and hippocampus, respectively.
“We observed that among the GFP-positive cells, 99.9 ± 0.17% and 99.7 ± 0.36% were Iba1 positive in the cortex and hippocampus, respectively (Fig. 2E,G);”
Quote in the paperSubstantial claim- Rests on an assumption: Endogenous Cx3cr1 is a selective marker for microglia in the CNS.
- Findingown data
In vehicle treated Cx3cr1-CreERT2J±;mT/mGf/- mice, up to 23.0 ± 3.4% of Iba1+ cells are GFP positive in the hippocampus.
“In vehicle treated mice, up to 18.9 ± 4.3% and 23.0 ± 3.4% of Iba1+ cells are GFP positive in the cortex and hippocampus, respectively.”
Quote in the paperSubstantial claim - Findingown data
In Cx3cr1-CreM±;Rosa-Greenf/- mice after pilocarpine-induced SE, 99.6 ± 0.24% of GFP+ cells were Iba1-positive in the hippocampus.
“In Cx3cr1-CreM±;Rosa-Greenf/-, we found that 98.8 ± 1.1% and 99.6 ± 0.24% of GFP+ cells were Iba1-positive in the cortex and hippocampus, respectively (two males and one female).”
Quote in the paperSubstantial claim - Findingown data
Lectin is colocalized with mTomato, confirming that mTomato is highly expressed in the blood vessels.
“We saw that lectin is colocalized with mTomato, confirming that mTomato is highly expressed in the blood vessels.”
Quote in the paperNot a substantial claim- The authors state this as an assumption: Mice are expected to express membrane tagged-Tomato (mTomato) ubiquitously independent of Cre recombinase, whereas expression of membrane tagged-GFP (mGFP) requires Cre-mediated homologous recombination.
- Findingown data
Among the other GFP+ cells in Cx3cr1-CreM±;Rosa-Greenf/- mice after SE, 0.31 ± 0.54% are NeuN positive in the cortex.
“Among the other GFP+ cells, only 0.31 ± 0.54% and 0.07 ± 0.13% are NeuN positive in the cortex and hippocampus, respectively and none of them are GFAP-positive (Fig. 4A–D).”
Quote in the paperSubstantial claim - Findingown data
In Cx3cr1-CreM±;Rosa-Greenf/- mice, 99.2 ± 0.3% and 99.8 ± 0.16% of microglia are GFP-positive in the cortex and hippocampus, respectively.
“We found that 99.2 ± 0.3% and 99.8 ± 0.16% of microglia are GFP-positive in the cortex and hippocampus, respectively (two males and three females; Fig. 2A–D).”
Quote in the paperSubstantial claim- Rests on an assumption: Endogenous Cx3cr1 is a selective marker for microglia in the CNS.
- Findingown data
None of the GFP-positive cells in Cx3cr1-Cre±;mT/mGf/- mice are either NeuN-positive or GFAP-positive.
“none of GFP+ cells are either NeuN-positive or GFAP-positive (two males and two females; Fig. 2F,H–J).”
Quote in the paperSubstantial claim- Rests on an assumption: Endogenous Cx3cr1 is a selective marker for microglia in the CNS.
- Findingown data
After tamoxifen treatment, all Iba1+ cells are GFP positive in Cx3cr1-CreERT2J±;mT/mGf/- mice.
“After tomaxifen treatment, all Iba1+ cells are GFP positive (two males and one female).”
Quote in the paperSubstantial claim - Findingown data
In the tdTomato mouse line, cre recombinase-independent leakage was observed predominantly in the hippocampus.
“In the tdTomato mouse line, we observed cre recombinase-independent leakage predominantly in the hippocampus, which is consistent with what is described at The Jackson Laboratory website, that the donating investigator reported a low level of fluorescent activity in this line.”
Quote in the paperSubstantial claim - Findingown data
Cre-dependent expression in the Cx3cr1-CreERT2J line is nearly completely restricted to microglia.
“However, the Cre-dependent expression is nearly completely restricted to microglia (Fig. 3A–F).”
Quote in the paperSubstantial claim - Findingown data
None of the GFP positive cells are GFAP-positive in Cx3cr1-CreERT2J±;mT/mGf/- mice.
“Again, none of GFP positive cells are either NeuN- or GFAP- positive.”
Quote in the paperSubstantial claim - Findingown data
tdTomato signal is co-localized with lectin, particularly in the hippocampus.
“We observed that tdTomato signal is co-localized with lectin, particularly in the hippocampus.”
Quote in the paperSubstantial claim - Findingown data
Some weak NeuN-positive cells in Rosa-Greenf/f mice lacked typical neuronal morphology.
“Notably, some weak NeuN-positive cells lacked typical neuronal morphology (Fig. 1C; Extended Data Fig. 2-1B,C).”
Quote in the paperNot a substantial claim - Findingown data
No leakage of mGFP expression was found over the entirety of the sections from all seven mT/mGf/f mice examined.
“We found no leakage of mGFP expression over the entirety of the sections from all seven mT/mGf/f mice we examined (three males and four females; Fig. 1E,F; Extended Data Fig. 1-1B).”
Quote in the paperSubstantial claim- The authors state this as an assumption: Mice are expected to express membrane tagged-Tomato (mTomato) ubiquitously independent of Cre recombinase, whereas expression of membrane tagged-GFP (mGFP) requires Cre-mediated homologous recombination.
- Findingown data
We did not find any significant transient Cx3cr1 activity in neurons and astrocytes under the conditions that animals experienced excitatory injury.
“Finally, we did not find any significant transient Cx3cr1 activity in neurons and astrocytes under the conditions that animals have experienced excitatory injury.”
Quote in the paperSubstantial claim - Findingown data
None of the GFP positive cells are NeuN-positive in Cx3cr1-CreERT2J±;mT/mGf/- mice.
“Again, none of GFP positive cells are either NeuN- or GFAP- positive.”
Quote in the paperSubstantial claim - Findingown data
Among the other GFP+ cells in Cx3cr1-CreM±;Rosa-Greenf/- mice after SE, 0.07 ± 0.13% are NeuN positive in the hippocampus.
“Among the other GFP+ cells, only 0.31 ± 0.54% and 0.07 ± 0.13% are NeuN positive in the cortex and hippocampus, respectively and none of them are GFAP-positive (Fig. 4A–D).”
Quote in the paperSubstantial claim - Findingown data
Cx3cr1-CreERT2J±;mT/mGf/- mice displayed significant expression of GFP reporter in microglia even without tamoxifen treatment.
“We found that Cx3cr1-CreERT2J±;mT/mGf/- mice displayed significant expression of GFP reporter in microglia even without tamoxifen treatment (one male and two females; Fig. 3A–F).”
Quote in the paperSubstantial claim - Interpretationown data
Two previously created Cx3cr1-Cre lines remain invaluable tools for studying microglia.
“Together, our findings confirm that two previously created Cx3cr1-Cre lines remain as invaluable tools for studying microglia.”
Quote in the paperSubstantial claim- Rests on an assumption: Endogenous Cx3cr1 is a selective marker for microglia in the CNS.
- Interpretationown data
In the Cx3cr1-CreERT2J mouse line, Cre-ERT2 recombinase possesses some basal enzymatic activity independent of tamoxifen.
“These data suggest that in this Cx3cr1-CreERT2J mouse line, Cre-ERT2 recombinase possesses some basal enzymatic activity independent of tamoxifen.”
Quote in the paperSubstantial claim - Interpretationnone given
The non-microglial GFP-positive cells in Cx3cr1-CreM±;Rosa-Greenf/- mice likely result from leakage of the Rosa-Green reporter itself.
“These non-microglial GFP-positive cells likely result from leakage of the Rosa-Green reporter itself.”
Quote in the paperNot a substantial claim - Interpretationown data
There is significant leakage of tdTomato expression into the blood vessels in the CNS in the absence of Cre recombinase.
“This data suggests that there is a significant leakage of tdTomato expression into the blood vessels in the CNS in the absence of cre recombinase.”
Quote in the paperSubstantial claim - Interpretationnone given
Those non-microglial GFP-positive cells are presumably from the spontaneous leakiness of the Rosa-Greenf/f reporter.
“Those non-microglial GFP-positive cells are presumably from the spontaneous leakiness of the Rosa-Greenf/f reporter.”
Quote in the paperNot a substantial claim - Study design and conductown data
Both pairs of anti-Iba1 and anti-NeuN antibodies used to detect microglia and neurons are cell-type specific.
“Both pairs of antibodies are cell-type specific (Extended Data Fig. 1-3A,B ).”
Quote in the paperNot a substantial claim - Interpretationown data
The mT/mGf/f line is a reliable reporter for evaluating Cre lines in the CNS.
“Therefore, we conclude that the mT/mGf/f line is a reliable reporter for evaluating Cre lines in the CNS.”
Quote in the paperSubstantial claim- The authors state this as an assumption: Mice are expected to express membrane tagged-Tomato (mTomato) ubiquitously independent of Cre recombinase, whereas expression of membrane tagged-GFP (mGFP) requires Cre-mediated homologous recombination.
- Interpretationown data
The Cx3cr1-CreM± line drives microglial-specific expression of floxed GFP reporters.
“Taken together, these data suggest that the Cx3cr1-CreM± line drives microglial-specific expression of floxed GFP reporters.”
Quote in the paperSubstantial claim- Rests on an assumption: Endogenous Cx3cr1 is a selective marker for microglia in the CNS.
- Interpretationreasoning
Given that the Rosa-Greenf/f reporter line itself has spontaneous leakiness, this complicates the data interpretation.
“Given that the Rosa- Greenf/f reporter line itself has spontaneous leakiness, this complicates the data interpretation.”
Quote in the paperSubstantial claim - Interpretationown data
tdTomato predominantly labels vascular structures in the CNS.
“It appears that tdTomato predominantly labels vascular structures in the CNS.”
Quote in the paperSubstantial claim - Interpretationown data
Our data confirm there is little or no transient Cx3cr1-driven Cre activity in neurons or astrocytes in brains that experienced SE.
“Thus, our data confirm there is little or no transient Cx3cr1-driven Cre activity in neurons or astrocytes in brains that experienced SE.”
Quote in the paperSubstantial claim - Interpretationown data
Our data with reporter lines suggest there is very minimal, if any, transient Cx3cr1 activity in neurons or astrocytes following excitatory injury.
“In contrast, our data with reporter lines suggest there is very minimal, if any, transient Cx3cr1 activity in neurons or astrocytes following excitatory injury.”
Quote in the paperSubstantial claim - Interpretationreasoning
Increased gene dosage from BAC duplication may create issues including genetic instability and ectopic gene expression.
“This may create issues related to increased gene dosage, which could have unexpected effects, including genetic instability and ectopic gene expression.”
Quote in the paperNot a substantial claim - Interpretationreasoning
The BAC strategy may cause duplication of the genes brought in within the BAC constructs.
“A drawback of this approach is it may cause duplication of the genes brought in within the BAC constructs.”
Quote in the paperNot a substantial claim - Premisecitation
All four microglia-targeting Cre lines were created using a BAC strategy.
“All four microglia-targeting Cre lines were created using a BAC strategy, which involves insertion of a large piece of DNA containing not only the gene promoter of interest, but also many other regulatory elements that help to yield the expected expression pattern of the endogenous gene (Gong et al., 2003, 2007).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Gong et al., 2003, 2007
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Classified as probably not a substantial claim. 11
- May combine two claims. 13
- The quote only partly states this claim. 1
Classified as probably not a substantial claim.
PremisecitationCx3cr1-CreERT2 developed by Jung et al. (2000) was reported to drive microglia-specific expression.
“Cx3cr1-CreERT2 developed by Jung et al. (2000) was reported to drive microglia-specific expression.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Jung et al. (2000) source
The Results and Discussion describe a CX3CR1-GFP reporter mouse, not a Cx3cr1-CreERT2 mouse. Although GFP was observed in microglia, the same section reports expression in peripheral blood monocytes and subsets of NK and dendritic cells, contrary to microglia-specific expression. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationWang et al. reported that transient expression of Cx3cr1 in neurons is neuronal protective in an ischemic model.
“Wang et al., reported that transient expression of Cx3cr1 in neurons is neuronal protective in an ischemic model (Wang et al., 2018).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Wang et al., 2018 source
The Discussion states the opposite: elevated neuronal CX3CR1 is associated with apoptotic death, while CX3CR1 deficiency protects against ischemic brain damage. The study used a permanent, not transient, ischemia model. The supplied passages have section labels but no page numbers. (LLM, conf=0.94)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
Classified as probably not a substantial claim.
PremisecitationThe leakiness of this Cx3cr1-Cre line was recently reported, but in conjunction with a Rosa-Greenf/f reporter line (Zhang et al., 2018).
“The leakiness of this Cx3cr1-Cre line was recently reported, but in conjunction with a Rosa-Greenf/f reporter line (Zhang et al., 2018).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Zhang et al., 2018 source
May combine two claims.
InterpretationreasoningIf the YFP reporter line has no spontaneous leakiness, then the constitutive Cx3cr1-Cre line developed by Jung et al. (2000), now available at The Jackson Laboratory, is not microglia specific.
“If the YFP reporter line has no spontaneous leakiness, then the constitutive Cx3cr1-Cre line developed by Jung et al. (2000), and which is now available at The Jackson Laboratory, is not microglia specific.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Jung et al. (2000) source
The Results and Discussion report CX3CR1 expression in microglia and in non-microglial cells, including peripheral blood monocytes and dendritic cells, supporting the concern about microglia specificity. But the Generation of CX3CR-1GFP mice section describes an EGFP knock-in, not a constitutive Cx3cr1-Cre line. Our copy does not establish that Jung et al. developed the Cre line, that it is available at The Jackson Laboratory, or how it behaves with a YFP reporter. (LLM, conf=0.85)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIn Hwang et al. (2017), the GFP reporter line was created by the researchers themselves.
“Moreover, in the same study, the GFP reporter line was created by the researchers themselves.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Hwang et al., 2017 source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe Cx3cr1-CreM line was deployed in Hwang et al. (2017), who found it to drive microglial-specific expression of a reporter.
“Notably, this Cre-line was also deployed in a recent study by Hwang et al. (2017), who found it to drive microglial-specific expression of a reporter.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Hwang et al. (2017) source
The Results section (page unavailable) reports that Cx3cr1-Cre; Pabpc1cTag mice showed highly restricted PABP-GFP expression matching cell-type markers, supporting the reporter-expression finding. But the paper calls the line Cx3cr1-Cre, not Cx3cr1-CreM, and STAR Methods (page unavailable) notes occasional GFP expression in neurons; our copy therefore does not establish the exact line designation or absolute microglial specificity. (LLM, conf=0.82)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationHwang et al. (2017) briefly mentioned that ∼10% of their animals displayed significant leakage into neurons, but the data were not provided.
“However, the authors also briefly mentioned that ∼ 10% of their animals displayed significant leakage into neurons, but the data were not provided (Hwang et al., 2017).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Hwang et al., 2017 source
STAR METHODS (Experimental Model and Subject Details; page unavailable) reports occasional GFP-expression leakiness in neuronal lineages in fewer than 10% of tested Cx3cr1-Cre; Pabpc1cTag mice. This supports the central observation, but the paper does not call the leakage significant or give a figure documenting those cases; its stated rate is <10%, rather than approximately 10%. (LLM, conf=0.87)
Experimental — accuracy not yet measured
Classified as probably not a substantial claim. May combine two claims.
PremisecitationThe expression pattern of Cx3cr1-driven GFP reporter is specific to microglia over the entire period of postnatal brain development and appears to be maintained even following an excitatory injury.
“The expression pattern of Cx3cr1-driven GFP reporter is specific to microglia over the entire period of postnatal brain development and appears to be maintained even following an excitatory injury (Kim et al., 2015).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Kim et al., 2015 source
In Results (‘Cx3Cr1GFP/+ are identified as microglia’; page unavailable), GFP substantially overlaps the microglial marker IBA1 in P15 mice both before and after febrile seizures, and microglia greatly outnumber infiltrating macrophages and monocytes after induced seizures. But the paper says Cx3Cr1 can also be expressed by other antigen-presenting cells, so the reporter is not established as specific to microglia. Although the developmental study spans P0–P60, reporter specificity was checked at P15, not throughout that period. (LLM, conf=0.88)
Experimental — accuracy not yet measured
May combine two claims.
Findingown dataTamoxifen treatment led to broad expression of GFP reporter in microglia, without significant leakage into neurons, in the Cx3cr1-CreERT2 line developed by Jung et al. (2000).
“Nevertheless, tamoxifen treatment led to broad expression of GFP reporter in microglia, without significant leakage into neurons.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Jung et al. (2000) source
The Results and Discussion (page not available in our copy) report GFP expression in microglia of CX3CR1+/GFP mice. The Methods and Results describe a GFP knock-in, not a Cx3cr1-CreERT2 line, and do not report tamoxifen treatment or assess GFP leakage into neurons; the stated absence of GFP concerns astrocytes and oligodendrocytes. (LLM, conf=0.90)
Experimental — accuracy not yet measured
Classified as probably not a substantial claim. May combine two claims.
PremisecitationMeucci et al. (2000) reported that Cx3cr1 is expressed in cultured neurons and promotes neuronal survival.
“Meucci et al. (2000) reported that Cx3cr1is expressed in cultured neurons and promotes neuronal survival.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Meucci et al. (2000) source
May combine two claims.
PremisecitationIn Wang et al., the IHC data showed that the majority of Cx3cr1-positive cells were neurons and very few, if any, were microglia.
“However, oddly, the IHC data showed that the majority of Cx3cr1-positive cells were neurons and very few, if any, were microglia.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Wang et al., 2018 source
In Results, Figure 2, the double staining is described as showing CX3CR1 mainly in ischemic neurons, supporting the majority-neuronal part of the claim. The same Results section reports CX3CR1 upregulation in microglia at a relatively lower level at 24 hours, but does not establish that very few, if any, CX3CR1-positive cells were microglia. (LLM, conf=0.86)
Experimental — accuracy not yet measured
May combine two claims.
Findingown dataAmong GFP-positive cells in the cortex of Rosa-Greenf/f mice, Iba1+, NeuN+, and GFAP+ populations are 2.80 ± 2.45%, 17.42 ± 15.66%, and 0%, respectively.
“Among the GFP-positive cells in the cortex, Iba1+, NeuN+, and GFAP+ populations are 2.80 ± 2.45%, 17.42 ± 15.66%, and 0%, respectively.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe leakiness of GFP reporter in Rosa-Greenf/f mice varied significantly between the two hemispheres and among animals even in the same age group.
“The leakiness varied significantly between the two hemispheres (Extended Data Fig. 1-1A) and among animals even in the same age group.”
Quote in the paperSubstantial claimThe quote only partly states this claim.
Findingown dataThe entire mouse body can turn pinkish in color in tdTomato mice with broad spontaneous leakage.
“The entire mouse body can turn pinkish in color.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn Cx3cr1-CreM±;Rosa-Greenf/- mice, NeuN+/GFP+ and GFAP+/GFP+ populations are 0.13 + 0.5% and 0% in cortex, and 0% and 0.2 ± 0.5% in hippocampus, respectively.
“NeuN+/GFP+ and GFAP+/GFP+ populations are 0.13 + 0.5% and 0%, in the cortex, and 0% and 0.2 ± 0.5% in the hippocampus, respectively.”
Quote in the paperSubstantial claim- Rests on an assumption: Endogenous Cx3cr1 is a selective marker for microglia in the CNS.
May combine two claims.
Findingown datamTomato is expressed in various brain structures but is noticeably present in the hippocampal CA3 area and in the blood vessels.
“Indeed, mTomato is expressed in various brain structures but is noticeably present in the hippocampal CA3 area and in the blood vessels (Extended Data Fig. 1-2C,D).”
Quote in the paperNot a substantial claim- The authors state this as an assumption: Mice are expected to express membrane tagged-Tomato (mTomato) ubiquitously independent of Cre recombinase, whereas expression of membrane tagged-GFP (mGFP) requires Cre-mediated homologous recombination.
May combine two claims.
Findingown dataIn the hippocampus of tdTomato reporter mice, Iba1+, NeuN+, and GFAP+ populations are 0, 44 ± 0.9%, 0.70 ± 1.6%, and 0.88 ± 1.2%, respectively.
“In the hippocampus, Iba1+, NeuN+, and GFAP+ populations are 0, 44 ± 0.9%, 0.70 ± 1.6%, and 0.88 ± 1.2%, respectively.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAmong tdTomato-positive cells in the cortex, Iba1+, NeuN+, and GFAP+ populations are 2.00 ± 4.5%, 4.00 ± 8.9%, and 0%, respectively.
“Among the tdTomato positive cells in the cortex, Iba1+, NeuN+, and GFAP+ populations are 2.00 ± 4.5%, 4.00 ± 8.9%, and 0%, respectively.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S2 (checkable), S4 (based).
InterpretationreasoningIn the absence of a reliable anti-Cx3cr1 antibody, it is hard to draw any conclusions from these studies.
“In the absence of a reliable anti-Cx3cr1 antibody, it is hard to draw any conclusions from these studies.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIn Yeo et al., nearly 100% of the Cx3cr1-positive cells were astrocytes.
“Nearly 100% of the Cx3cr1-positive cells were astrocytes.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Yeo et al. (2011) source
Classified as probably not a substantial claim.
PremisecitationYeo et al. (2011) reported that pilocarpine-triggered SE induced very moderate expression of Cx3cr1 in astrocytes.
“Yeo et al. (2011) reported that pilocarpine-triggered SE induced very moderate expression of Cx3cr1 in astrocytes, but again the IHC data are puzzling.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Yeo et al. (2011) source
The paper relies on this without support.
Endogenous Cx3cr1 is a selective marker for microglia in the CNS.
“Endogenous Cx3cr1 is a selective marker for microglia in the CNS, whereas its ligand fractalkine is expressed in neurons.”
The authors state this as an assumption.
Mice are expected to express membrane tagged-Tomato (mTomato) ubiquitously independent of Cre recombinase, whereas expression of membrane tagged-GFP (mGFP) requires Cre-mediated homologous recombination.
“Mice are expected to express membrane tagged-Tomato (mTomato) ubiquitously independent of cre recombinase whereas the expression of membrane tagged-GFP(mGFP) requires cre-mediated homologous recombination.”
The paper relies on this without support.
The reliability of Cre-dependent GFP reporter lines has not been seriously evaluated or even discussed.
“While Cre lines have been blamed for the cause of leakiness into neurons, the reliability of Cre-dependent GFP reporter lines has not been seriously evaluated or even discussed.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
The same stock number identifies two different mouse lines
MinorStock #005582 is identified first as a Cx3cr1-GFP reporter line and later as a Cx3cr1-CreERT2 inducible Cre line. These are described as different genetic tools.
“The Cx3cr1-GFP reporter line (stock #005582; The Jackson Laboratory) was created by replacing the coding part of the Cx3cr1 gene with green fluorescent protein (GFP; Jung et al., 2000).”
“inducible B6.129P-Cx3cr1tm1Litt /J (Cx3cr1-CreERT2, stock#:005582; The Jackson Laboratory) Cre lines (Zhang et al., 2018).”
Cites
Modification of seizure activity by electrical stimulation: II. Motor seizure
Racine, R. J. (1972) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(72)90177-0 · Cited by 7,141 · see citing works
Fate Mapping Reveals Origins and Dynamics of Monocytes and Tissue Macrophages under Homeostasis
Yona, S., Kim, K.-W., Wolf, Y., Mildner, A., Varol, D., Breker, M., Strauss-Ayali, D., Viukov, S., Guilliams, M., Misharin, A., et al. (2013) · Immunity · doi:10.1016/j.immuni.2012.12.001 · Cited by 3,245 · see citing works
Jung, S., Aliberti, J., Graemmel, P., Sunshine, M. J., Kreutzberg, G. W., Sher, A., & Littman, D. R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.11.4106-4114.2000 · Cited by 2,632 · see citing works
Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor
Parkhurst, C. N., Yang, G., Ninan, I., Savas, J. N., Yates, J. R., Lafaille, J. J., Hempstead, B. L., Littman, D. R., & Gan, W.-B. (2013) · Cell · doi:10.1016/j.cell.2013.11.030 · Cited by 2,599 · see citing works
A gene expression atlas of the central nervous system based on bacterial artificial chromosomes
Gong, S., Zheng, C., Doughty, M. L., Losos, K., Didkovsky, N., Schambra, U. B., Nowak, N. J., Joyner, A., Leblanc, G., Hatten, M. E., et al. (2003) · Nature · doi:10.1038/nature02033 · Cited by 2,108 · see citing works
Increasing adult hippocampal neurogenesis is sufficient to improve pattern separation
Sahay, A., Scobie, K. N., Hill, A. S., O'Carroll, C. M., Kheirbek, M. A., Burghardt, N. S., Fenton, A. A., Dranovsky, A., & Hen, R. (2011) · Nature · doi:10.1038/nature09817 · Cited by 1,567 · see citing works
Gong, S., Doughty, M., Harbaugh, C. R., Cummins, A., Hatten, M. E., Heintz, N., & Gerfen, C. R. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2707-07.2007 · Cited by 977 · see citing works
Neuronal and glial pathological changes during epileptogenesis in the mouse pilocarpine model
Borges, K. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00086-4 · Cited by 396 · see citing works
Expression of CX <sub>3</sub> CR1 chemokine receptors on neurons and their role in neuronal survival
Meucci, O., Fatatis, A., Simen, A. A., & Miller, R. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.090017497 · Cited by 385 · see citing works
Peng, J., Gu, N., Zhou, L., B Eyo, U., Murugan, M., Gan, W.-B., & Wu, L.-J. (2016) · Nature Communications · doi:10.1038/ncomms12029 · Cited by 300 · see citing works
Re-evaluating microglia expression profiles using RiboTag and cell isolation strategies
Haimon, Z., Volaski, A., Orthgiess, J., Boura-Halfon, S., Varol, D., Shemer, A., Yona, S., Zuckerman, B., David, E., Chappell-Maor, L., et al. (2018) · Nature Immunology · doi:10.1038/s41590-018-0110-6 · Cited by 209 · see citing works
Noninflammatory Changes of Microglia Are Sufficient to Cause Epilepsy
Zhao, X., Liao, Y., Morgan, S., Mathur, R., Feustel, P., Mazurkiewicz, J., Qian, J., Chang, J., Mathern, G. W., Adamo, M. A., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.02.004 · Cited by 190 · see citing works
Self-citationMüller, C. J., Gröticke, I., Bankstahl, M., & Löscher, W. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.05.035 · Cited by 169 · see citing works
Kim, I., Mlsna, L. M., Yoon, S., Le, B., Yu, S., Xu, D., & Koh, S. (2015) · Brain and Behavior · doi:10.1002/brb3.403 · Cited by 91 · cited 2× · see citing works
“The expression pattern of Cx3cr1-driven GFP reporter is specific to microglia over the entire period of postnatal brain development and appears to be maintained even following an excitatory injury (Kim et al., 2015).”
BackgroundInfluentialHwang, H.-W., Saito, Y., Park, C. Y., Blachère, N. E., Tajima, Y., Fak, J. J., Zucker-Scharff, I., & Darnell, R. B. (2017) · Neuron · doi:10.1016/j.neuron.2017.08.024 · Cited by 74 · see citing works
Mazzetti, S., Frigerio, S., Gelati, M., et al. (2009) · European Journal of Histochemistry · doi:10.4081/916 · Cited by 73 · see citing works
Genetic manipulation of microglia during brain development and disease
Wieghofer, P., & Prinz, M. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.09.019 · Cited by 58 · see citing works
Ischemia-induced Neuronal Cell Death Is Mediated by Chemokine Receptor CX3CR1
Wang, J., Gan, Y., Han, P., Yin, J., Liu, Q., Ghanian, S., Gao, F., Gong, G., & Tang, Z. (2018) · Scientific Reports · doi:10.1038/s41598-017-18774-0 · Cited by 58 · cited 3× · see citing works
“Transient Cx3cr1 activity in neurons and astrocytes following excitatory injury Cx3cr1 was reported to be expressed in cultured neurons and induced in neurons and astrocytes following brain ischemia and severe seizures, respectively (Meucci et al., 2000; Yeo et al., 2011; Dworzak et al., 2015; Wang et al., 2018).”
BackgroundYeo, S.-I., Kim, J.-E., Ryu, H. J., Seo, C. H., Lee, B. C., Choi, I.-G., Kim, D.-S., & Kang, T.-C. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.03.005 · Cited by 55 · see citing works
Zhang, B., Zou, J., Han, L., Beeler, B., Friedman, J. L., Griffin, E., Piao, Y., Rensing, N. R., & Wong, M. (2018) · Epilepsia · doi:10.1111/epi.14526 · Cited by 50 · see citing works
Neuronal Cx3cr1 Deficiency Protects against Amyloid β-Induced Neurotoxicity
Dworzak, J., Renvoisé, B., Habchi, J., Yates, E. V., Combadière, C., Knowles, T. P., Dobson, C. M., Blackstone, C., Paulsen, O., & Murphy, P. M. (2015) · PLOS ONE · doi:10.1371/journal.pone.0127730 · Cited by 30 · see citing works
Subbanna, S., Nagre, N. N., Shivakumar, M., Joshi, V., Psychoyos, D., Kutlar, A., Umapathy, N. S., & Basavarajappa, B. S. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00045 · Cited by 29 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Astrocytic interleukin-3 programs microglia and limits Alzheimer’s disease
McAlpine, C. S., Park, J., Griciuc, A., Kim, E., Choi, S. H., Iwamoto, Y., Kiss, M. G., Christie, K. A., Vinegoni, C., Poller, W. C., et al. (2021) · Nature · doi:10.1038/s41586-021-03734-6 · Cited by 322 · see citing works
Cien Años de Microglía: Milestones in a Century of Microglial Research
Sierra, A., Paolicelli, R. C., & Kettenmann, H. (2019) · Trends in Neurosciences · doi:10.1016/j.tins.2019.09.004 · Cited by 229 · see citing works
APOE4 impairs the microglial response in Alzheimer’s disease by inducing TGFβ-mediated checkpoints
Yin, Z., Rosenzweig, N., Kleemann, K. L., Zhang, X., Brandão, W., Margeta, M. A., Schroeder, C., Sivanathan, K. N., Silveira, S., Gauthier, C., et al. (2023) · Nature Immunology · doi:10.1038/s41590-023-01627-6 · Cited by 202 · see citing works
Type-I-interferon-responsive microglia shape cortical development and behavior
Escoubas, C. C., Dorman, L. C., Nguyen, P. T., Lagares-Linares, C., Nakajo, H., Anderson, S. R., Barron, J. J., Wade, S. D., Cuevas, B., Vainchtein, I. D., et al. (2024) · Cell · doi:10.1016/j.cell.2024.02.020 · Cited by 179 · see citing works
Klawonn, A. M., Fritz, M., Castany, S., Pignatelli, M., Canal, C., Similä, F., Tejeda, H. A., Levinsson, J., Jaarola, M., Jakobsson, J., et al. (2021) · Immunity · doi:10.1016/j.immuni.2020.12.016 · Cited by 161 · see citing works
Microglial Gi-dependent dynamics regulate brain network hyperexcitability
Merlini, M., Rafalski, V. A., Ma, K., Keun-young Kim, A., Bushong, E. A., Coronado, P. E. R., Yan, Z., Mendiola, A. S., Sözmen, E. G., Ryu, J. K., et al. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-00756-7 · Cited by 146 · see citing works
Chemogenetic manipulation of microglia inhibits neuroinflammation and neuropathic pain in mice
Yi, M., Liu, Y., Liu, K., Chen, T., Bosco, D. B., Zheng, J., Xie, M., Zhou, L., Qu, W., & Wu, L. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.11.030 · Cited by 147 · see citing works
Microglial depletion aggravates the severity of acute and chronic seizures in mice
Wu, W., Li, Y., Wei, Y., Bosco, D. B., Xie, M., Zhao, M., Richardson, J. R., & Wu, L. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.06.028 · Cited by 133 · see citing works
mTOR and neuroinflammation in epilepsy: implications for disease progression and treatment
Ravizza, T., Scheper, M., Di Sapia, R., Gorter, J., Aronica, E., & Vezzani, A. (2024) · Nature Reviews Neuroscience · doi:10.1038/s41583-024-00805-1 · Cited by 141 · see citing works
Augusto‐Oliveira, M., Arrifano, G. D. P., Delage, C. I., Tremblay, M., Lopez, M. E. C., & Verkhratsky, A. (2021) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12797 · Cited by 107 · see citing works
Quantifying microglial morphology: an insight into function
Green, T. R. F., & Rowe, R. K. (2024) · Clinical & Experimental Immunology · doi:10.1093/cei/uxae023 · Cited by 106 · see citing works
ATP-releasing SWELL1 channel in spinal microglia contributes to neuropathic pain
Chu, J., Yang, J., Zhou, Y., Chen, J., Chen, K. H., Zhang, C., Cheng, Y., Koylass, N., Liu, J. O., Guan, Y., et al. (2023) · Science Advances · doi:10.1126/sciadv.ade9931 · Cited by 99 · see citing works
A neurodegenerative cellular stress response linked to dark microglia and toxic lipid secretion
Flury, A. G., Aljayousi, L., Park, H.-J., Khakpour, M., Mechler, J., Aziz, S., McGrath, J. D., Deme, P., Sandberg, C., Ibáñez, F. G., et al. (2024) · Neuron · doi:10.1016/j.neuron.2024.11.018 · Cited by 98 · see citing works
Distinct Features of Brain-Resident Macrophages: Microglia and Non-Parenchymal Brain Macrophages
Lee, E., Eo, J.-C., Lee, C., & Yu, J. (2021) · Molecules and Cells · doi:10.14348/molcells.2021.0060 · Cited by 75 · see citing works
Heterogeneity analysis of astrocytes following spinal cord injury at single‐cell resolution
Hou, J., Bi, H., Ge, Q., Teng, H., Wan, G., Yu, B., Jiang, Q. Y., & Gu, X. (2022) · The FASEB Journal · doi:10.1096/fj.202200463r · Cited by 67 · see citing works
Reiss, D. J., Maduna, T., Maurin, H., Audouard, E., & Gavériaux‐Ruff, C. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24626 · Cited by 62 · see citing works
Saika, F., Matsuzaki, S., Kobayashi, D., Ideguchi, Y., Nakamura, T. Y., Kishioka, S., & Kiguchi, N. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00925 · Cited by 63 · see citing works
Tackling the glial scar in spinal cord regeneration: new discoveries and future directions
Shafqat, A., Albalkhi, I., Magableh, H. M., Saleh, T., AlKattan, K. M., & Yaqinuddin, A. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1180825 · Cited by 67 · see citing works
Jiang, D., Burger, C. A., Akhanov, V., Liang, J. H., Mackin, R. D., Albrecht, N. E., Andrade, P., Schafer, D. P., & Samuel, M. A. (2022) · Immunity · doi:10.1016/j.immuni.2022.10.018 · Cited by 62 · see citing works
Zhao, X., Liao, Y., Alam, M. M., Mathur, R., Feustel, P. J., Mazurkiewicz, J. E., Adamo, M. A., Zhu, X. C., & Huang, Y. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.2754-19.2020 · Cited by 58 · see citing works
Self-citationMicroglia-derived extracellular vesicles trigger age-related neurodegeneration upon DNA damage
Arvanitaki, E. S., Goulielmaki, E., Gkirtzimanaki, K., Niotis, G., Tsakani, E., Nenedaki, E., Rouska, I., Kefalogianni, M., Xydias, D., Kalafatakis, I., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2317402121 · Cited by 50 · see citing works
Huck, N. A., Siliezar-Doyle, J., Haight, E. S., Ishida, R., Forman, T. E., Wu, S., Shen, H., Takemura, Y., Clark, J. D., & Tawfik, V. L. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.1940-20.2021 · Cited by 51 · see citing works
Pan, L., Cho, K.-S., Wei, X., Xu, F., Lennikov, A., Hu, G., Tang, J., Guo, S., Chen, J., Kriukov, E., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112889 · Cited by 52 · see citing works
Hohsfield, L. A., Najafi, A. R., Ghorbanian, Y., Soni, N., Crapser, J. D., Velez, D. X. F., Jiang, S., Royer, S. E., Kim, S. J., Henningfield, C. M., et al. (2021) · eLife · doi:10.7554/elife.66738 · Cited by 46 · see citing works
Basilico, B., Ferrucci, L., Khan, A., Angelantonio, S. D., Ragozzino, D., & Reverte, I. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.1022431 · Cited by 48 · see citing works
Microglial-specific depletion of TAK1 is neuroprotective in the acute phase after ischemic stroke
Zeyen, T., Noristani, R., Habib, S. A. J., Heinisch, O., Slowik, A., Huber, M., Schulz, J. B., Reich, A., & Habib, P. (2020) · Journal of Molecular Medicine · doi:10.1007/s00109-020-01916-9 · Cited by 47 · see citing works
Droho, S., Thomson, B. R., Makinde, H. M., Cuda, C. M., Perlman, H., & Lavine, J. A. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-02010-0 · Cited by 46 · see citing works
Regulation of neuropathic pain by microglial Orai1 channels
Tsujikawa, S., DeMeulenaere, K. E., Centeno, M. V., Ghazisaeidi, S., Martin, M. E., Tapies, M. G. R., Maneshi, M. M., Yamashita, M., Stauderman, K. A., Apkarian, A. V., et al. (2023) · Science Advances · doi:10.1126/sciadv.ade7002 · Cited by 42 · see citing works
Investigating Microglia in Health and Disease: Challenges and Opportunities
Miron, V. E., & Priller, J. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.07.002 · Cited by 41 · see citing works
Microglia are not protective against cryptococcal meningitis
Mohamed, S. H., Fu, M. S., Hain, S., Alselami, A., Vanhoffelen, E., Li, Y., Bojang, E., Lukande, R. L., Ballou, E. R., May, R. C., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43061-0 · Cited by 35 · see citing works
Opposing effects of the purinergic P2X7 receptor on seizures in neurons and microglia in male mice
Alves, M., Gil, B., Villegas-Salmerón, J., Salari, V., Martins-Ferreira, R., Blázquez, M. A., Méndez, A. M., Gerbatin, R. R., Smith, J., de Diego-García, L., et al. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.05.023 · Cited by 36 · see citing works
Role of myeloid cells in ischemic retinopathies: recent advances and unanswered questions
Shahror, R. A., Morris, C., Mohammed, A. A., Wild, M., Zaman, B., Mitchell, C. D., Phillips, P. H., Rusch, N. J., Shosha, E., & Fouda, A. Y. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03058-y · Cited by 34 · see citing works
S100A10 and its binding partners in depression and antidepressant actions
Chen, M. X., Oh, Y., & Kim, Y. D. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.953066 · Cited by 32 · see citing works
Subbanna, S., Nagre, N. N., Shivakumar, M., Joshi, V., Psychoyos, D., Kutlar, A., Umapathy, N. S., & Basavarajappa, B. S. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00045 · Cited by 29 · see citing works
Advances in Visualizing Microglial Cells in Human Central Nervous System Tissue
Uff, C. E. G., Patel, K., Yeung, C., & Yip, P. K. (2022) · Biomolecules · doi:10.3390/biom12050603 · Cited by 26 · see citing works
DePaula-Silva, A. B. (2024) · Viruses · doi:10.3390/v16010119 · Cited by 27 · see citing works
Ramírez-Fernández, A., Urbina-Treviño, L., Conte, G., Alves, M., Rissiek, B., Durner, A., Scalbert, N., Zhang, J., Magnus, T. U., Koch‐Nolte, F., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-76428-0 · Cited by 22 · see citing works
Alam, M. M., Zhao, X., Liao, Y., Mathur, R., McCallum, S. E., Mazurkiewicz, J. E., Adamo, M. A., Feustel, P. J., Belin, S., Poitelon, Y., et al. (2021) · eNeuro · doi:10.1523/eneuro.0183-20.2021 · Cited by 21 · see citing works
Self-citationSalcido, F. A. M., Torres-Flores, M. I., Ordaz, B., & Peña‐Ortega, F. (2022) · Glia · doi:10.1002/glia.24185 · Cited by 21 · see citing works
Reduction in GABAB on glia induce Alzheimer’s disease related changes
Osse, A. M. L., Pandey, R. S., Wirt, R. A., Ortiz, A. A., Salazar, A., Kimmich, M. J., Strom, E. N. T., Oblak, A. L., Lamb, B. T., Hyman, J. M., et al. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.03.002 · Cited by 19 · see citing works
Bobotis, B. C., Halvorson, T., Carrier, M., & Tremblay, M. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1317125 · Cited by 21 · see citing works
Microglia Mediate Metabolic Dysfunction From Common Air Pollutants Through NF-κB Signaling
Debarba, L. K., Jayarathne, H. S. M., Stilgenbauer, L., dos Santos, A. L. T., Koshko, L., Scofield, S., Sullivan, R. P., Mandal, A., Klueh, U., & Sadagurski, M. (2024) · Diabetes · doi:10.2337/db24-0110 · Cited by 17 · see citing works
CX3CL1 Regulation of Gliosis in Neuroinflammatory and Neuroprotective Processes
Gutiérrez, I. L., Martín‐Hernández, D., MacDowell, K. S., García‐Bueno, B., Caso, J. R., Leza, J. C., & Madrigal, J. L. M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26030959 · Cited by 17 · see citing works
IRF5 Signaling in Phagocytes Is Detrimental to Neonatal Hypoxic Ischemic Encephalopathy
Mamun, A. A., Yu, H., Sharmeen, R., McCullough, L. D., & Liu, F. (2020) · Translational Stroke Research · doi:10.1007/s12975-020-00832-x · Cited by 17 · see citing works
Primary cilia-mediated regulation of microglial secretion in Alzheimer’s disease
Yeo, S., Jang, J., Jung, H. J., Lee, H., & Choe, Y. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1250335 · Cited by 18 · see citing works
Pathogenesis and therapeutic applications of microglia receptors in Alzheimer’s disease
Fu, J., Wang, R., He, J., Liu, X., Wang, X., Yao, J., Liu, Y., Ran, C., Ye, Q., & He, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1508023 · Cited by 16 · see citing works
Ni, R., 四川大学华西医院精神卫生中心和精神医学研究室, 四. 成. 6., Wang, Y., Gao, T.-H., Wang, Q., Wei, J., Zhao, L., Ma, Y.-R., Ma, X., Li, T., et al. (2023) · 动物学研究 · doi:10.24272/j.issn.2095-8137.2022.389 · Cited by 18 · see citing works
Huang, J., Hu, X., Chen, Z., Ouyang, F., Li, J., Hu, Y., Zhao, Y., Wang, J., Yao, F., Jing, J., et al. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03089-5 · Cited by 17 · see citing works
Ni, R., Yuan, W.-J., Wang, Y., Yang, X., Wei, J., Zhao, L., Wang, Q., Tang, X., & Ma, X. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03525-x · Cited by 16 · see citing works
Yasui, H., Matsuzaki, Y., Konno, A., & Hirai, H. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.04.004 · Cited by 14 · see citing works
Clarifying the ability of NeuroD1 to convert mouse microglia into neurons
Matsuda, T., & Nakashima, K. (2021) · Neuron · doi:10.1016/j.neuron.2021.11.012 · Cited by 16 · see citing works
Iida, T., Yanai, K., & Yoshikawa, T. (2022) · Current topics in behavioral neurosciences · doi:10.1007/7854_2022_322 · Cited by 13 · see citing works
Polo-like kinase 2 promotes microglial activation via regulation of the HSP90α/IKKβ pathway
Cheng, J., Wu, L., Chen, X., Li, S., Xu, Z., Sun, R., Huang, Y., Wang, P., Ouyang, J., Pei, P., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114827 · Cited by 12 · see citing works
Self-citationMaes, M. E., Wögenstein, G. M., Colombo, G., Casado-Polanco, R., & Siegert, S. (2021) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2021.09.006 · Cited by 12 · see citing works
Stilgenbauer, L., Chen, Q., Pungi, D., James, N. M., Jayarathne, H. S. M., Koshko, L., Scofield, S., Zhang, K., & Sadagurski, M. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102128 · Cited by 11 · see citing works
Xie, X., Liu, J., Liang, W., Zhang, Y., Gong, X., Yuan, S., Qi, C., Huang, M., Shi, L., Hou, M., et al. (2026) · Immunity · doi:10.1016/j.immuni.2026.01.014 · Cited by 10 · see citing works
Yang, H., Yang, J., Park, N., Hwang, D., Park, S.-Y., Kim, S., & Bae, H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413682 · Cited by 10 · see citing works
Madalena, K. M., Brennan, F. H., & Popovich, P. G. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.114114 · Cited by 10 · see citing works
Lenoël, I., Ribon, M., Lorenc, F., Diebold, A., Philibert, C. E., Robaldo, D., Badsi, M., Perronnet, J., Lameth, J., Berriat, F., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-63211-w · Cited by 10 · see citing works
Izzy, S., Yahya, T., Albastaki, O., Cao, T., Schwerdtfeger, L., Abou‐El‐Hassan, H., Chopra, K., Ekwudo, M. N., Kurdeikaite, U., Verissimo, I. M., et al. (2024) · Brain Communications · doi:10.1093/braincomms/fcae147 · Cited by 7 · see citing works
Brocardo, L., Acosta, L. E., Piantanida, A. P., & Rela, L. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00491 · Cited by 7 · see citing works
DeMeulenaere, K. E., Grant, R. A., Martin, M. E., Abdala‐Valencia, H., Radulović, J., Salter, M. W., & Prakriya, M. (2026) · Science Signaling · doi:10.1126/scisignal.ady8398 · Cited by 7 · see citing works
Collado-Solé, A., Borjini, N., Zhai, J., Ruíz-Pino, F., Soria-Alcaide, G., Folgueira, C., Vilela, C. G., la Rosa, B. R.-D., López, V., Zouaghi, Y., et al. (2026) · Science · doi:10.1126/science.aeb6999 · Cited by 6 · see citing works
Liu, Z., Liu, K., Shi, S., Chen, X., Gu, X., Wang, W., Mao, K., Yibulayi, R., Wu, W., Zeng, L., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.175479 · Cited by 6 · see citing works
Liu, Y., Yao, F., Li, Z., Jiang, Y. P., Li, J., Yu, S., Hu, X., Ouyang, F., Zheng, M., Li, C., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03445-z · Cited by 6 · see citing works
Optic Nerve Crush Does Not Induce Retinal Ganglion Cell Loss in the Contralateral Eye
Uiterkamp, F. E. S., Maes, M. E., Alamalhoda, M., Firoozi, A., Colombo, G., & Siegert, S. (2025) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.66.3.49 · Cited by 5 · see citing works
Brain Perivascular Macrophages Do Not Mediate Interleukin-1-Induced Sickness Behavior in Rats
Chaskiel, L., Dantzer, R., & Konsman, J. P. (2021) · Pharmaceuticals · doi:10.3390/ph14101030 · Cited by 5 · see citing works
Mouse Models to Study Peroxisomal Functions and Disorders: Overview, Caveats, and Recommendations
Kocherlakota, S., Swinkels, D., Veldhoven, P. P. V., & Baes, M. I. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3048-8_34 · Cited by 5 · see citing works
Kaiser, T., Dattero, J., Li, L., Chen, M., Jiang, M., Harrahill, A., Butovsky, O., & Feng, G. (2024) · eNeuro · doi:10.1523/eneuro.0549-23.2024 · Cited by 7 · see citing works
Wu, S., Shen, S., Sun, W., Zhao, Y., Zhang, J., Wang, Z., Cai, W. L., Lu, Z., & Qiu, W. (2025) · The FASEB Journal · doi:10.1096/fj.202500075rr · Cited by 4 · see citing works
Glotfelty, E. J., Coke, L. M., Hart, E. E., Rivell, C., Phan, A., Greer, B. D., Svarcbahs, R., Fielding, E., Necarsulmer, J., Fortuno, L. V., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-31077-z · Cited by 4 · see citing works
Nanoparticles: The new promise for region-specific targeting of microglia
Nadjar, A. (2022) · Matter · doi:10.1016/j.matt.2022.06.048 · Cited by 4 · see citing works
Neurofibromatosis type 1-dependent alterations in mouse microglia function are not cell-intrinsic
Logiacco, F., Grzegorzek, L. C., Cordell, E., Popp, O., Mertins, P., Gutmann, D. H., Kettenmann, H., & Semtner, M. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01525-w · Cited by 4 · see citing works
Hayashi, K., Lesnak, J. B., Plumb, A. N., Janowski, A. J., Rasmussen, L. A., Vignes, H., Flanagan, R., Berardi, G., Paradee, W. J., & Sluka, K. A. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.106122 · Cited by 4 · see citing works
Li, Y., Lei, Z., Ritzel, R. M., He, J., Liu, S., Zhang, L., & Wu, J. (2024) · Cells · doi:10.3390/cells13181584 · Cited by 3 · see citing works
Microglia protect fungi against copper starvation and promote brain infectionPreprint
Mohamed, S. H., Fu, M. S., Hain, S., Alselami, A., Vanhoffelen, E., Li, Y., Bojang, E., Lukande, R. L., Ballou, E. R., May, R. C., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.07.506901 · Cited by 3 · see citing works
Comprehensive analysis of myeloid reporter micePreprint
Wang, Y., Dowling, S. D., Rodriguez, V., Maciuch, J., Mayer, M., Therron, T., Shaw, T. N., Gurra, M. G., Shah, C. L., Makinde, H. M., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.24.639159 · Cited by 2 · see citing works
The role of RNA modifications in disease-associated macrophages
Huart, C., Gupta, M. S., & Ginderachter, J. A. V. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102315 · Cited by 3 · see citing works
Debarba, L. K., Jayarathne, H. S. M., Stilgenbauer, L., dos Santos, A. L. T., Koshko, L., Scofield, S., Sullivan, R., Mandal, A., Klueh, U., & Sadagurski, M. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.08.566279 · Cited by 2 · see citing works
A Common Iba1 Antibody Labels Vasopressin Neurons in Mice
Lichtenstein, H. D., Kamau, F., McGrath, S., Stern, J. E., & Bolton, J. L. (2026) · eNeuro · doi:10.1523/eneuro.0323-25.2025 · Cited by 1 · see citing works
The Arp2/3 complex controls the development of homeostatic microglia
Safaiyan, S., Frosch, M., Bickel, T., Monaco, G., Dvir, R., Madry, C., Bosch, L. F. P., Kierdorf, K., Innocenti, M., Priller, J., et al. (2026) · EMBO Reports · doi:10.1038/s44319-026-00721-8 · Cited by 1 · see citing works
White, A. M., Craig, A. J., Richie, D. L., Corley, C. L., Bondy, E. O., Kendrick, P. T., McManus, H., Sadek, S. M., Scofield, M. D., & Gipson, C. D. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.18.643780 · Cited by 1 · see citing works
Pallais, J. P., Razzoli, M., Rodriguez, P., McGonigle, S., Daugherty, A. L., Hillman, H., Verteramo, L., Schrank, P. R., Parthiban, P., Chang, X., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.18.719397 · Cited by 1 · see citing works
Deftu, A., & Suter, M. R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-809324-5.24214-4
Unexpected failure of rod bipolar cell targeting using L7Cre-2 mice
Peperstraete, K., Baes, M. I., & Swinkels, D. (2023) · Experimental Eye Research · doi:10.1016/j.exer.2023.109406
Huang, J., Hu, X., Chen, Z., Ouyang, F., Li, J., Hu, Y., Zhao, Y., Wang, J., Yao, F., Jing, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25583940
McSwain, L., Kim, K., Hwang, D., Lim, C., Winham, C. L., Jacques, J., Jonus, H. C., Rosen, E. P., Pradhan, A., Kasturi, S. P., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.07.714454
Xin, T., Kong, D., Shi, M., Wei, C., Chen, G., Wang, S., Zhao, S., Ma, Y., Jin, X., & Liu, Z. (2026) · Brain Research · doi:10.1016/j.brainres.2026.150332
Bryniarska, N., Kubiak, A., Trojan, E., et al. (2026) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6c00005
REID, L., Ganapathiraju, S. V., Mancinelli, S. M., Kagan, D., Sprouse, G., Li, A., Fazio, M., German, W., Fan, C., Saengsot, R., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-62223-w
Self-citationUtility of the Recombinase Driver CX3CR1-ERT2 Rat Strain in Nicotine Self-Administration
White, A. M., Craig, A. J., Richie, D. L., Corley, C. L., Kendrick, P. T., McNealy, K. R., Scofield, M. D., & Gipson, C. D. (2026) · Cells · doi:10.3390/cells15161445
A critical in vivo role for microglial p38α MAPK in HIV-1 associated inflammatory brain injury
Bhullar, D., Maung, R., Roberts, A. J., Murad, R., Carson, M. J., & Kaul, M. (2026) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2026.107004
McPherson, S. W., Burgstaler, L., Sherman, J., Patin, A., & Roehrich, H. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1951506
- Authors
- Zhao, X.-F., Alam, M. M., Liao, Y., Huang, T., Mathur, R., Zhu, X., & Huang, Y.
- Affiliations
- Albany Medical College (US)
- Venue
- eneuro
- Publisher
- Society for Neuroscience
- Published
- 2019-06-14
- Volume
- 6
- Issue
- 4
- Pages
- ENEURO.0114-19.2019
- ISSN
- 2373-2822 (ISSN-L)
- PMC
- PMC6620394
- OpenAlex
- W2952334185
- Semantic Scholar
- f910172e9ddfe7401266957cddf7fc92354df01b
- Cited by
- 92
- References
- 22
- Citations by year
- 2026: 13 · 2025: 12 · 2024: 19 · 2023: 13 · 2022: 10 · 2021: 9 · 2020: 13 · 2019: 2 · 2018: 1
- FWCI
- 3.14
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- eNeuro (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (submittedVersion, cc-by)
- Funders
- HHS | NIH | National Institute of Neurological Disorders and Stroke (NS093045)
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (DK099566)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- microglia, astrocytes, neurons, CNS homeostasis
- MeSH terms
- CX3C Chemokine Receptor 1, Animals, Astrocytes, Brain, Female, Male, Mice, Transgenic, Neurons, Reproducibility of Results, Gene Expression, Microglia, Genes, Reporter, Integrases, Green Fluorescent Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-20.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-20.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review